Citigroup’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.14M | Sell |
48,337
-6,809
| -12% | -$174K | ﹤0.01% | 3032 |
|
|
2025
Q4 | $1.6M | Buy |
55,146
+9,235
| +20% | +$236K | ﹤0.01% | 2807 |
|
|
2025
Q3 | $865K | Sell |
45,911
-313,511
| -87% | -$4.94M | ﹤0.01% | 3251 |
|
|
2025
Q2 | $5.04M | Buy |
359,422
+57,870
| +19% | +$811K | ﹤0.01% | 1883 |
|
|
2025
Q1 | $4.72M | Sell |
301,552
-25,713
| -8% | -$362K | ﹤0.01% | 1947 |
|
|
2024
Q4 | $4.56M | Buy |
327,265
+237,643
| +265% | +$2.6M | ﹤0.01% | 2058 |
|
|
2024
Q3 | $833K | Buy |
89,622
+35,023
| +64% | +$346K | ﹤0.01% | 3405 |
|
|
2024
Q2 | $508K | Sell |
54,599
-661,841
| -92% | -$5.99M | ﹤0.01% | 3385 |
|
|
2024
Q1 | $7.1M | Buy |
716,440
+703,727
| +5,535% | +$5.25M | 0.01% | 1476 |
|
|
2023
Q4 | $41.1K | Sell |
12,713
-164,109
| -93% | -$446K | ﹤0.01% | 4620 |
|
|
2023
Q3 | $939K | Buy |
176,822
+23,234
| +15% | +$198K | ﹤0.01% | 2576 |
|
|
2023
Q2 | $1.46M | Sell |
153,588
-90,411
| -37% | -$1M | ﹤0.01% | 2516 |
|
|
2023
Q1 | $2.68M | Buy |
243,999
+110,771
| +83% | +$1.6M | ﹤0.01% | 1823 |
|
|
2022
Q4 | $1.97M | Sell |
133,228
-27,273
| -17% | -$476K | ﹤0.01% | 2047 |
|
|
2022
Q3 | $3.07M | Buy |
160,501
+114,683
| +250% | +$2.6M | ﹤0.01% | 1843 |
|
|
2022
Q2 | $976K | Buy |
45,818
+34,215
| +295% | +$702K | ﹤0.01% | 2672 |
|
|
2022
Q1 | $223K | Sell |
11,603
-108,637
| -90% | -$1.84M | ﹤0.01% | 4028 |
|
|
2021
Q4 | $2.49M | Buy |
120,240
+95,304
| +382% | +$1.9M | ﹤0.01% | 2437 |
|
|
2021
Q3 | $596K | Sell |
24,936
-36,483
| -59% | -$832K | ﹤0.01% | 3491 |
|
|
2021
Q2 | $1.68M | Buy |
61,419
+8,087
| +15% | +$228K | ﹤0.01% | 2803 |
|
|
2021
Q1 | $1.54M | Buy |
53,332
+47,904
| +883% | +$1.5M | ﹤0.01% | 2666 |
|
|
2020
Q4 | $153K | Sell |
5,428
-4,456
| -45% | -$109K | ﹤0.01% | 5185 |
|
|
2020
Q3 | $290K | Buy |
9,884
+6,873
| +228% | +$184K | ﹤0.01% | 4311 |
|
|
2020
Q2 | $91K | Sell |
3,011
-3
| -0.1% | -$87 | ﹤0.01% | 5650 |
|
|
2020
Q1 | $90K | Buy |
+3,014
| New | +$81K | ﹤0.01% | 5420 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
